Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hanall Biopharma (009420 KS)
Watchlist
15
Analysis
Health Care
•
South Korea
HANALL BIOPHARMA CO., LTD. manufactures prescription drugs for hospitals. The Company specializes in making oral and non-oral antibiotics and amino-acid infusions.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
HBM Holdings Limited
•
26 Nov 2020 16:49
HBM Holdings (Harbour Biomed) IPO Initiation: Making Resistance Futile
Harbour is seeking to raise $300 million through a Hong Kong IPO. Harbour’s three antibody platforms are a key source of differentiation. Overall,...
Arun George
Follow
464 Views
Share
bullish
•
MSCI Emerging Markets Index
•
09 Sep 2020 20:57
Remain Overweight EM Relative To EAFE
The MSCI EM index (local currency) remains in an uptrend and is testing all-time highs set in January 2018 near 65,800; as long as the index is...
Vermilion Research
Follow
354 Views
Share
bearish
•
Daewoong Pharmaceutical Co
•
28 Mar 2019 07:36
Daewoong: Entering "Botox World"
Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...
Kemp Dolliver, CFA
509 Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Jul 2016 00:13
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
Sanghyun Park
Follow
3.4k Views
Share
First
Previous
1
2
3
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.10
x